International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation(ISHLT).

[1]  C. Smith.  Patient selection, evaluation, and preoperative management for lung transplant candidates. , 1997, Clinics in chest medicine.

[2]  P. Gilligan,et al.  The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. , 1997, American journal of respiratory and critical care medicine.

[3]  G. Patterson,et al.  Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. , 1996, The Journal of thoracic and cardiovascular surgery.

[4]  L Goldman,et al.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.

[5]  R. Casaburi,et al.  Lung volume reduction surgery. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, May 1996. , 1996, American journal of respiratory and critical care medicine.

[6]  T. Egan,et al.  Severe osteoporosis before and after lung transplantation. , 1996, Chest.

[7]  B. Groves,et al.  Pulmonary hypertension in chronic liver disease. , 1996, Clinics in chest medicine.

[8]  P. Macklem,et al.  Nutritional status and mortality in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[9]  B. Groves,et al.  A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. , 1996, The New England journal of medicine.

[10]  R. Mckenna,et al.  A randomized, prospective trial of stapled lung reduction versus laser bullectomy for diffuse emphysema. , 1996, The Journal of thoracic and cardiovascular surgery.

[11]  R. Wu,et al.  Changes in pulmonary function test results after 1 year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis. , 1995, Chest.

[12]  W. Gersony,et al.  Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. , 1995, Circulation.

[13]  J. Peters,et al.  Single lung transplantation in patients with systemic disease. , 1994, Chest.

[14]  D. Schwartz,et al.  Determinants of survival in idiopathic pulmonary fibrosis. , 1994, American journal of respiratory and critical care medicine.

[15]  D. Geddes,et al.  Cystic fibrosis in the United Kingdom, 1968-1988: incidence, population and survival. , 1993, Paediatric and perinatal epidemiology.

[16]  D. Cattran,et al.  CYCLOSPORINE NEPHROTOXICITY IN LUNG TRANSPLANT RECIPIENTS , 1992, Transplantation.

[17]  M. Corey,et al.  Prediction of mortality in patients with cystic fibrosis. , 1992, The New England journal of medicine.

[18]  E H Bergofsky,et al.  Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .

[19]  G. Raghu,et al.  Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. , 1991, The American review of respiratory disease.

[20]  R. Calne,et al.  TRANSPLANTATION OF LIVER, HEART, AND LUNGS FOR PRIMARY BILIARY CIRRHOSIS AND PRIMARY PULMONARY HYPERTENSION , 1987, The Lancet.

[21]  B. Burrows,et al.  Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival , 1980, Thorax.

[22]  B. Griffith,et al.  Critical issues in pediatric lung transplantation. , 1995, The Journal of thoracic and cardiovascular surgery.

[23]  D. Stover,et al.  Lung transplantation for chemotherapy-induced pulmonary fibrosis. , 1994, Chest.